• 1
    Takezaki H, Hanaoka M. The use of carbamazepine (Tegretol) in the controlled manic-depressive psychosis and other manic, depressive states. Seishin Igaku 1971; 13: 173182 (in Japanese).
  • 2
    Chung WH, Hung SI, Hong HS et al. Medical genetics: A marker for Stevens-Johnson syndrome. Nature 2004; 428: 486.
  • 3
    Hung SI, Chung WH, Jee SH et al. Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions. Pharmacogenet. Genomics 2006; 16: 297306.
  • 4
    Chen P, Lin JJ, Lu CS et al. Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan. N. Eng. J. Med. 2011; 364: 11261133.
  • 5
    Chang CJ. Genotyping HLA-B*1502 and the revised act for compensation of drug-induced adverse effects in Taiwan. Taiwan Journal of Psychiatry (Taipei) 2011; 25: 123125.